Hindustan Unilever Ltd.

Further to its letter dated 22nd January 2025, wherein the company had intimated that pursuant to approval of the Board of Directors, the Company had signed and executed the Share Purchase and Subscription Agreement for acquisition of 90.5% of shareholding of Uprising Science (‘Uprising’) comprising secondary buyout and a primary infusion, with an eventual acquisition of the remaining 9.5% of Uprising’s shareholding as per the terms set out therein (‘Proposed Acquisition’). Pursuant to Regulation 30(7) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Hindustan Unilever has informed that the Competition Commission of India (‘CCI’) vide its letter dated 17th March 2025 has accorded its approval for the Proposed Acquisition. A copy of the letter is enclosed. The detailed order of CCI is awaited.

The above information is a part of company’s filings submitted to BSE.